Advances in Neurostimulation for Treatment-Resistant Depression and Chronic Pain: Emerging Neuromodulation Strategies in Modern Clinical Neuroscience
DOI:
https://doi.org/10.64784/245Keywords:
Neurostimulation, Neuromodulation, Treatment-Resistant Depression, Chronic Pain, Repetitive Transcranial Magnetic Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Spinal Cord Stimulation, Dorsal Root Ganglion Stimulation, Psychiatry, Neurology, Neurosurgery, Pain Medicine, Precision Medicine, Neural NetworksAbstract
Treatment-resistant depression and chronic pain represent major global health challenges due to their high prevalence, significant disability burden, and limited response to conventional therapeutic approaches. Recent advances in neuroscience have improved understanding of the neural networks involved in emotional regulation, cognitive processing, and pain modulation, leading to the development of innovative neuromodulation strategies. This review analyzes current evidence regarding neurostimulation therapies used in the management of treatment-resistant depression and chronic pain, including repetitive transcranial magnetic stimulation, transcranial direct current stimulation, vagus nerve stimulation, deep brain stimulation, spinal cord stimulation, and dorsal root ganglion stimulation. A scientific-method-based literature review was conducted using publications indexed in major biomedical databases. The findings indicate that neurostimulation offers clinically meaningful benefits in selected patients by directly modulating dysfunctional neural circuits associated with symptom persistence. Repetitive transcranial magnetic stimulation demonstrated strong evidence in treatment-resistant depression, while spinal cord stimulation and dorsal root ganglion stimulation showed substantial effectiveness in refractory neuropathic pain conditions. The review also highlights the importance of individualized treatment selection, safety considerations, technological innovation, and multidisciplinary collaboration. Furthermore, emerging developments involving adaptive stimulation systems, artificial intelligence, biomarker-guided interventions, and precision neuromodulation may significantly influence future clinical practice. Neurostimulation is increasingly recognized as a valuable component of modern neurological, psychiatric, neurosurgical, and pain management strategies, with growing implementation across diverse healthcare systems, including Latin America. Continued research and technological advancement are expected to further expand its therapeutic potential and improve outcomes for patients with complex and refractory disorders.
References
[1] J. P. O’Reardon et al., “Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression,” Biol. Psychiatry, vol. 62, no. 11, pp. 1208–1216, 2007, doi: 10.1016/j.biopsych.2007.01.018.
[2] A. J. Rush et al., “Vagus nerve stimulation for treatment-resistant depression: A randomized, controlled acute phase trial,” Biol. Psychiatry, vol. 58, no. 5, pp. 347–354, 2005, doi: 10.1016/j.biopsych.2005.05.025.
[3] A. J. Rush et al., “Effects of 12 months of vagus nerve stimulation in treatment-resistant depression,” Biol. Psychiatry, vol. 58, no. 5, pp. 355–363, 2005, doi: 10.1016/j.biopsych.2005.05.024.
[4] M. S. George et al., “A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression,” Biol. Psychiatry, vol. 58, no. 5, pp. 364–373, 2005, doi: 10.1016/j.biopsych.2005.07.028.
[5] P. E. Holtzheimer et al., “Subcallosal cingulate deep brain stimulation for treatment-resistant depression: A multi-site, randomized, sham-controlled trial,” Lancet Psychiatry, vol. 4, no. 11, pp. 839–849, 2017, doi: 10.1016/S2215-0366(17)30371-1.
[6] A. R. Brunoni et al., “Trial of electrical direct-current therapy versus escitalopram for depression,” N. Engl. J. Med., vol. 376, no. 26, pp. 2523–2533, 2017, doi: 10.1056/NEJMoa1612999.
[7] D. M. Blumberger et al., “Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression,” Lancet, vol. 391, no. 10131, pp. 1683–1692, 2018, doi: 10.1016/S0140-6736(18)30295-2.
[8] S. M. McClintock et al., “Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation in the treatment of depression,” J. Clin. Psychiatry, vol. 79, no. 1, 2018, doi: 10.4088/JCP.16cs10905.
[9] J. P. Lefaucheur et al., “Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation,” Clin. Neurophysiol., vol. 131, no. 2, pp. 474–528, 2020, doi: 10.1016/j.clinph.2019.11.002.
[10] C. R. Conway, S. T. Aaronson, and H. A. Sackeim, “Vagus nerve stimulation in treatment-resistant depression,” Brain Stimul., 2024, doi: 10.1016/j.brs.2024.12.1191.
[11] H. Knotkova, M. Hamani, E. Sivanesan, A. Le Beuffe, D. Moon, B. Cohen, and A. Huntoon, “Neuromodulation for chronic pain,” Lancet, vol. 397, no. 10289, pp. 2111–2124, 2021, doi: 10.1016/S0140-6736(21)00794-7.
[12] K. Kumar et al., “Spinal cord stimulation versus conventional medical management for neuropathic pain,” Pain, vol. 132, no. 1–2, pp. 179–188, 2007, doi: 10.1016/j.pain.2007.07.028.
[13] L. Kapural et al., “Novel 10-kHz high-frequency therapy is superior to traditional low-frequency spinal cord stimulation,” Anesthesiology, vol. 123, no. 4, pp. 851–860, 2015, doi: 10.1097/ALN.0000000000000774.
[14] T. R. Deer et al., “Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia,” Pain, vol. 158, no. 4, pp. 669–681, 2017, doi: 10.1097/j.pain.0000000000000814.
[15] E. Petersen et al., “Effect of high-frequency 10-kHz spinal cord stimulation in patients with painful diabetic neuropathy,” JAMA Neurol., vol. 78, no. 6, pp. 687–698, 2021, doi: 10.1001/jamaneurol.2021.0538.
[16] Y. Zheng et al., “Neurostimulation for chronic pain: A systematic review of randomized controlled trials,” Pain Physician, vol. 26, no. 4, pp. 367–384, 2023.
[17] S. Campos-Fajardo et al., “Effectiveness of dorsal root ganglion stimulation in chronic pain: A systematic review,” Neuromodulation, 2024, doi: 10.1016/j.neurom.2024.05.007.
[18] A. F. Baptista et al., “Latin American and Caribbean consensus on noninvasive central nervous system neuromodulation for chronic pain management,” Pain Rep., vol. 4, no. 1, e692, 2019, doi: 10.1097/PR9.0000000000000692.
[19] C. Amescua-García et al., “Most relevant neuropathic pain treatment and chronic low back pain management guidelines: A Change Pain Latin America advisory panel consensus,” Pain Med., vol. 19, no. 3, pp. 460–470, 2018, doi: 10.1093/pm/pnx198.
[20] V. Quintero-Carreño, J. C. Benavides, and J. C. Acevedo, “Spinal cord stimulation in the management of neuropathic pain,” Rev. Colomb. Anestesiol., vol. 49, no. 2, 2021, doi: 10.5554/22562087.e962.
